D.E. Shaw & Co’s CME Group CME Stock Holding History

D.E. Shaw & Co’s Portfolio CME Stock Details CME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$12.1M	Sell	40,900 -16,100	-28%	-$4.78M	0.01%	1487
2025 Q4	$15.6M	Buy	57,000 +1,000	+2%	+$272K	0.01%	1410
2025 Q3	$15.1M	Buy	56,000 +33,200	+146%	+$9.03M	0.01%	1374
2025 Q2	$6.28M	Buy	22,800 +17,800	+356%	+$4.84M	﹤0.01%	1850
2025 Q1	$1.33M	Sell	5,000 -55,000	-92%	-$13.6M	﹤0.01%	2898
2024 Q4	$13.9M	Buy	60,000 +30,000	+100%	+$6.9M	0.01%	1277
2024 Q3	$6.62M	Buy	30,000 +20,000	+200%	+$4.14M	0.01%	1731
2024 Q2	$1.97M	Hold	10,000	–	–	﹤0.01%	2671
2024 Q1	$2.15M	Sell	10,000 -10,000	-50%	-$2.1M	﹤0.01%	2578
2023 Q4	$4.21M	Buy	20,000 +10,000	+100%	+$2.13M	﹤0.01%	2052
2023 Q3	$2M	Sell	10,000 -15,000	-60%	-$2.98M	﹤0.01%	2563
2023 Q2	$4.63M	Buy	25,000 +15,000	+150%	+$2.77M	﹤0.01%	1902
2023 Q1	$1.92M	Sell	10,000 -20,000	-67%	-$3.62M	﹤0.01%	2726
2022 Q4	$5.04M	Buy	30,000 +20,000	+200%	+$3.48M	0.01%	2091
2022 Q3	$1.77M	Sell	10,000 -600	-6%	-$119K	﹤0.01%	3109
2022 Q2	$2.17M	Buy	10,600 +600	+6%	+$127K	﹤0.01%	2996
2022 Q1	$2.38M	Hold	10,000	–	–	﹤0.01%	3143
2021 Q4	$2.29M	Hold	10,000	–	–	﹤0.01%	3234
2021 Q3	$1.93M	Sell	10,000 -20,000	-67%	-$4.05M	﹤0.01%	3061
2021 Q2	$6.38M	Buy	30,000 +28,300	+1,665%	+$5.98M	0.01%	1847
2021 Q1	$347K	Buy	+1,700	New	+$335K	﹤0.01%	3651
2020 Q4	–	Sell	-13,800	Closed	-$2.31M	–	3939
2020 Q3	$2.31M	Sell	13,800 -25,900	-65%	-$4.36M	﹤0.01%	2305
2020 Q2	$6.45M	Buy	+39,700	New	+$7.12M	0.01%	1473
2020 Q1	–	Sell	-12,000	Closed	-$2.41M	–	3960
2019 Q4	$2.41M	Buy	12,000 +2,000	+20%	+$410K	﹤0.01%	2320
2019 Q3	$2.11M	Hold	10,000	–	–	﹤0.01%	2300
2019 Q2	$1.94M	Buy	+10,000	New	+$1.84M	﹤0.01%	2260
2018 Q4	–	Sell	-17,900	Closed	-$3.05M	–	3782
2018 Q3	$3.05M	Hold	17,900	–	–	﹤0.01%	1914
2018 Q2	$2.93M	Buy	+17,900	New	+$2.92M	﹤0.01%	1943
2018 Q1	–	Sell	-20,000	Closed	-$2.92M	–	3521
2017 Q4	$2.92M	Buy	+20,000	New	+$2.85M	﹤0.01%	1868
2016 Q1	–	Sell	-10,000	Closed	-$906K	–	3458
2015 Q4	$906K	Sell	10,000 -10,000	-50%	-$941K	﹤0.01%	2706
2015 Q3	$1.85M	Sell	20,000 -10,000	-33%	-$951K	﹤0.01%	2157
2015 Q2	$2.79M	Hold	30,000	–	–	﹤0.01%	1931
2015 Q1	$2.84M	Buy	30,000 +10,000	+50%	+$926K	﹤0.01%	1772
2014 Q4	$1.77M	Sell	20,000 -210,800	-91%	-$17.9M	﹤0.01%	2367
2014 Q3	$18.5M	Buy	230,800 +12,600	+6%	+$950K	0.02%	742
2014 Q2	$15.5M	Sell	218,200 -12,000	-5%	-$845K	0.02%	833
2014 Q1	$17M	Hold	230,200	–	–	0.02%	732
2013 Q4	$18.1M	Sell	230,200 -88,200	-28%	-$6.91M	0.02%	745
2013 Q3	$23.5M	Sell	318,400 -58,600	-16%	-$4.32M	0.04%	515
2013 Q2	$28.6M	Buy	+377,000	New	+$24.7M	0.05%	389

Other funds holding CME

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

D.E. Shaw & Co's CME Position: Q1 2026 in Review

D.E. Shaw & Co reduced its CME Group (CME) stake by 8.7% in Q1 2026, selling an estimated $3.88M and leaving 137,862 shares worth $40.7M. The position accounts for 0.02% of the portfolio, ranked #748.

D.E. Shaw & Co first reported a position in CME in Q2 2013 and has held it in 52 quarters since. The position peaked at $300M in Q3 2020. 1,790 funds tracked by Wall St. Rank hold CME as of Q1 2026.

D.E. Shaw & Co held 137,862 shares of CME Group worth $40.7M as of Q1 2026.
D.E. Shaw & Co sold 13,067 CME Group shares in Q1 2026, an estimated $3.88M.
CME Group made up 0.02% of D.E. Shaw & Co's portfolio in Q1 2026, its #748 holding.
D.E. Shaw & Co first reported a position in CME Group in Q2 2013 and has held it in 52 quarters since.
D.E. Shaw & Co's CME Group position peaked at $300M in Q3 2020.
1,790 funds tracked by Wall St. Rank held CME Group as of Q1 2026.

Based on D.E. Shaw & Co's 13F filing for Q1 2026, filed 15 May 2026.